
7 August 2026
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Group" or the "Company")
Grant of awards under Long-Term Incentive Plan
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, pioneering specialist neonatal intensive care medical devices, announces that on 6 August 2026, the Company awarded 2,759,141 options under the Inspiration Group plc Long Term Incentive Plan including 1,822,268 to its Chief Executive Officer and Chief Financial Officer as set out in the table below. The awards are over ordinary shares of £0.10 ("Ordinary Shares") in the form of options to acquire Ordinary Shares at nil cost ("Awards").
These awards reflect the annual issue of long term incentives and annual bonus awards under the Group's remuneration policy. The LTIP Awards will vest on the third anniversary of grant subject to meeting a minimum Adjusted EBITDA and Adjusted EBITDA to operating cashflow conversion targets over the three-year period ending on 31 January 2029. Bonus Awards relate to bonuses awarded for the financial year ended 31 January 2026 ("FY26"), vest immediately and can be exercised from the first anniversary of the award date.
|
Executive |
Role |
Number of Awards |
|
Raffi Stepanian |
Chief Executive Officer |
787,027 LTIP |
|
Raffi Stepanian |
Chief Executive Officer |
308,756 FY26 Bonus |
|
Alan Olby |
Chief Financial Officer |
494,918 LTIP |
|
Alan Olby |
Chief Financial Officer |
231,567 FY26 Bonus |
For further information, please contact:
|
Inspiration Healthcare Group plc |
Tel: +44 (0)330 175 0000 |
||||||
|
Raffi Stepanian, Chief Executive Officer Alan Olby, Chief Financial Officer |
|
||||||
|
|
|
||||||
|
Singer Capital Markets (Nominated Adviser & Broker) |
Tel: +44 (0)20 7496 3000 |
||||||
|
Alex Bond |
|
||||||
|
Patrick Weaver |
|
||||||
|
|
|
||||||
|
Cavendish Capital Markets (Joint Broker) |
Tel: + 44 (0)20 7220 0500 |
||||||
|
Giles Balleny / Joe Smith |
|
||||||
|
Nigel Birks |
|
||||||
|
Harriet Ward |
|
||||||
|
|
|
||||||
|
Walbrook PR Ltd (Media & IR) |
Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com |
||||||
|
Anna Dunphy |
Mob: +44 (0) 7876 741 001 |
||||||
|
Rachel Broad |
Mob: +44 (0) 7747 515 393 |
||||||
|
|
|
|
|||||

About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.
The Company has a broad portfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.
Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
|
1. Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) Name |
Harout Rafi Stepanian |
|
2. Reason for the notification |
|
|
a) Position/status |
PDMR (Chief Executive Officer) |
|
b) Initial notification / Amendment |
Initial notification |
|
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) Name |
Inspiration Healthcare Group plc |
|
b) LEI |
213800GKFT3ENAPMDL15 |
|
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) Description of the financial instrument, type of instrument / Identification code |
Options over Ordinary Shares of £0.10 each in the capital of the Company ISIN: GB00BXDZL105 |
|
b) Nature of the transaction |
Grant of options under the Inspiration Healthcare Group plc Long Term Incentive Plan |
|
c) Price(s) and volume(s) |
Price(s): Nil Volume(s): 787,027 |
|
d) Aggregated information - Aggregated volume, Price |
n/a |
|
e) Date of the transaction |
6 August 2026 |
|
f) Place of the transaction |
Off market |
|
1. Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) Name |
Harout Rafi Stepanian |
|
2. Reason for the notification |
|
|
a) Position/status |
PDMR (Chief Executive Officer) |
|
b) Initial notification / Amendment |
Initial notification |
|
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) Name |
Inspiration Healthcare Group plc |
|
b) LEI |
213800GKFT3ENAPMDL15 |
|
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) Description of the financial instrument, type of instrument / Identification code |
Options over Ordinary Shares of £0.10 each in the capital of the Company ISIN: GB00BXDZL105 |
|
b) Nature of the transaction |
Grant of options in respect of the FY26 annual bonus award |
|
c) Price(s) and volume(s) |
Price(s): Nil Volume(s): 308,756 |
|
d) Aggregated information - Aggregated volume, Price |
n/a |
|
e) Date of the transaction |
6 August 2026 |
|
f) Place of the transaction |
Off market |
|
1. Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) Name |
Alan Musgrave Olby |
|
2. Reason for the notification |
|
|
a) Position/status |
PDMR (Chief Financial Officer) |
|
b) Initial notification / Amendment |
Initial notification |
|
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) Name |
Inspiration Healthcare Group plc |
|
b) LEI |
213800GKFT3ENAPMDL15 |
|
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) Description of the financial instrument, type of instrument / Identification code |
Options over Ordinary Shares of £0.10 each in the capital of the Company ISIN: GB00BXDZL105 |
|
b) Nature of the transaction |
Grant of options under the Inspiration Healthcare Group plc Long Term Incentive Plan |
|
c) Price(s) and volume(s) |
Price(s): Nil Volume(s): 494,918 |
|
d) Aggregated information - Aggregated volume, Price |
n/a |
|
e) Date of the transaction |
6 August 2026 |
|
f) Place of the transaction |
Off market |
|
1. Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) Name |
Alan Musgrave Olby |
|
2. Reason for the notification |
|
|
a) Position/status |
PDMR (Chief Financial Officer) |
|
b) Initial notification / Amendment |
Initial notification |
|
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) Name |
Inspiration Healthcare Group plc |
|
b) LEI |
213800GKFT3ENAPMDL15 |
|
4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) Description of the financial instrument, type of instrument / Identification code |
Options over Ordinary Shares of £0.10 each in the capital of the Company ISIN: GB00BXDZL105 |
|
b) Nature of the transaction |
Grant of options in respect of the FY26 annual bonus award |
|
c) Price(s) and volume(s) |
Price(s): Nil Volume(s): 231,567 |
|
d) Aggregated information - Aggregated volume, Price |
n/a |
|
e) Date of the transaction |
6 August 2026 |
|
f) Place of the transaction |
Off market |